ACKNOWLDEGEMENTS

This work would not have been possible without the invaluable support from the following people:

• Kriss Blumeyer and the entire High Throughput Screening group at Chugai Biopharmaceuticals, Inc. (V&P South)
• Carlos Barreda, formerly of CyBio, Inc.
• James Ridge, formerly of CyBio, Inc.